| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
| Net income (loss) | 177,803 | -28,021,113 | -3,747,212 |
| Unrealized gain on securities | NaN | NaN | -33,747 |
| Unrealized loss (gain) on marketable securities | -27,901 | -43,845 | NaN |
| Gain on settlement of accounts payable | NaN | 0 | 127,579 |
| Shares issued for services | NaN | NaN | 142,633 |
| Loss on settlement of debt (non-cash) | NaN | -16,595,746 | NaN |
| Gain on remeasurement of derivative liability | 706,056 | 1,352,889 | 128,101 |
| Stock-based compensation | 329,153 | 12,700,399 | NaN |
| Loss on derivative | NaN | NaN | 3,425,796 |
| Loss (gain) on derivative | NaN | -3,425,796 | NaN |
| Increase in unbilled receivable | 32,667 | NaN | NaN |
| Increase in accounts payable and accrued expenses | 61,257 | 46,855 | 307,229 |
| Net cash used in operating activities | -142,609 | -163,537 | -93,487 |
| Proceeds from short-term advances - related parties | NaN | 84,800 | NaN |
| Proceeds from short term advances related parties | NaN | NaN | 84,800 |
| Proceeds from note related parties | NaN | 518,000 | NaN |
| Net cash provided by financing activities | NaN | 518,000 | 84,800 |
| Net change in cash | -142,609 | 354,463 | -8,687 |
| Cash at beginning of period | 358,975 | 4,512 | 13,199 |
| Cash at end of period | 216,366 | 358,975 | 4,512 |
Balance Labs, Inc. (BLNC)
Balance Labs, Inc. (BLNC)